A preliminary study suggests that CTA can play the role cardiac MRI has been playing for detecting and quantifying myocardial infarction to estimate the potential success of coronary bypass graft surgery.
A preliminary study suggests that CTA can play the role cardiac MRI has been playing for detecting and quantifying myocardial infarction to estimate the potential success of coronary bypass graft surgery.
Establishing the feasibility of perfusion CT to do what cardiac MRA does for delayed-enhancement myocardial imaging could eliminate the need for cardiac MRA in this important function and help speed therapy decision-making for surgical candidates.
Dr. Yoon Jin Lee and colleagues working in Seoul, Korea, were encouraged by the results of 10-minute delayed-enhancement, ECG-gated examinations performed with dual-source CT and cardiac MR for 29 patients requiring pre-coronary artery bypass graft surgery workups.
Delayed-enhancement and infarction volumes over total myocardial volume were evaluated by two radiologists using a 19-segment model for dual-source CT and cardiac MR. Ventricular function measures were also acquired using both techniques. The myocardium was considered viable when delayed enhancement failed to reveal any transmural deficit of greater than 50%.
Delayed enhancement was observed in 17 patients with both cardiac MR and dual-source CT. Cardiac MR caught a delayed-enhancement void in one patient that was not seen with dual-source CT.
Lee noted that the percentage of infarction volume was not significantly different between the two modalities, though the correlation was strongest for patients with ventricular ejection fractions greater than 40%.
The sensitivity and specificity of dual-source CT for detecting transmural infarctions greater than 50% were 95% and 77% respectively.
Though larger multicenter randomized trials are needed to validate the findings, Lee’s work strongly suggests that perfusion CT will eventually challenge cardiac MR for this application.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.